Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

This article has no abstract
Epistemonikos ID: f34a13b1d1bf9c92bcba0c3cf9f5180550281cec
First added on: Feb 15, 2025